Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes.

Picou F, Vignon C, Debeissat C, Lachot S, Kosmider O, Gallay N, Foucault A, Estienne MH, Ravalet N, Bene MC, Domenech J, Gyan E, Fontenay M, Herault O.

Blood Adv. 2019 Dec 23;3(24):4271-4279. doi: 10.1182/bloodadvances.2019000677.

2.

Correction: Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.

Kouzi F, Zibara K, Bourgeais J, Picou F, Gallay N, Brossaud J, Dakik H, Roux B, Hamard S, Le Nail LR, Hleihel R, Foucault A, Ravalet N, Rouleux-Bonnin F, Gouilleux F, Mazurier F, Bene MC, Akl H, Gyan E, Domenech J, El-Sabban M, Herault O.

Oncogene. 2019 Nov 7. doi: 10.1038/s41388-019-1089-7. [Epub ahead of print]

PMID:
31700154
3.

Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.

Kouzi F, Zibara K, Bourgeais J, Picou F, Gallay N, Brossaud J, Dakik H, Roux B, Hamard S, Le Nail LR, Hleihel R, Foucault A, Ravalet N, Rouleux-Bonnin F, Gouilleux F, Mazurier F, Bene MC, Akl H, Gyan E, Domenech J, El-Sabban M, Herault O.

Oncogene. 2020 Feb;39(6):1198-1212. doi: 10.1038/s41388-019-1069-y. Epub 2019 Oct 24. Erratum in: Oncogene. 2019 Nov 7;:.

4.

MAbTope: A Method for Improved Epitope Mapping.

Bourquard T, Musnier A, Puard V, Tahir S, Ayoub MA, Jullian Y, Boulo T, Gallay N, Watier H, Bruneau G, Reiter E, Crépieux P, Poupon A.

J Immunol. 2018 Nov 15;201(10):3096-3105. doi: 10.4049/jimmunol.1701722. Epub 2018 Oct 15.

5.

n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation.

Picou F, Debeissat C, Bourgeais J, Gallay N, Ferrié E, Foucault A, Ravalet N, Maciejewski A, Vallet N, Ducrocq E, Haddaoui L, Domenech J, Hérault O, Gyan E.

Pharmacol Res. 2018 Oct;136:45-55. doi: 10.1016/j.phrs.2018.08.015. Epub 2018 Aug 22.

PMID:
30142422
6.

Human Luteinizing Hormone and Chorionic Gonadotropin Display Biased Agonism at the LH and LH/CG Receptors.

Riccetti L, Yvinec R, Klett D, Gallay N, Combarnous Y, Reiter E, Simoni M, Casarini L, Ayoub MA.

Sci Rep. 2017 Apr 19;7(1):940. doi: 10.1038/s41598-017-01078-8.

7.

Phosphorylation of β-arrestin2 at Thr383 by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs.

Cassier E, Gallay N, Bourquard T, Claeysen S, Bockaert J, Crépieux P, Poupon A, Reiter E, Marin P, Vandermoere F.

Elife. 2017 Feb 7;6. pii: e23777. doi: 10.7554/eLife.23777.

8.

Eculizumab epitope on complement C5: Progress towards a better understanding of the mechanism of action.

Brachet G, Bourquard T, Gallay N, Reiter E, Gouilleux-Gruart V, Poupon A, Watier H.

Mol Immunol. 2016 Sep;77:126-31. doi: 10.1016/j.molimm.2016.07.016. Epub 2016 Aug 5.

PMID:
27497837
9.

Role of Cysteine Residues in the Carboxyl-Terminus of the Follicle-Stimulating Hormone Receptor in Intracellular Traffic and Postendocytic Processing.

Melo-Nava B, Casas-González P, Pérez-Solís MA, Castillo-Badillo J, Maravillas-Montero JL, Jardón-Valadez E, Zariñán T, Aguilar-Rojas A, Gallay N, Reiter E, Ulloa-Aguirre A.

Front Cell Dev Biol. 2016 Jul 20;4:76. doi: 10.3389/fcell.2016.00076. eCollection 2016.

10.

Assessing Gonadotropin Receptor Function by Resonance Energy Transfer-Based Assays.

Ayoub MA, Landomiel F, Gallay N, Jégot G, Poupon A, Crépieux P, Reiter E.

Front Endocrinol (Lausanne). 2015 Aug 27;6:130. doi: 10.3389/fendo.2015.00130. eCollection 2015.

11.

Biased signalling in follicle stimulating hormone action.

Landomiel F, Gallay N, Jégot G, Tranchant T, Durand G, Bourquard T, Crépieux P, Poupon A, Reiter E.

Mol Cell Endocrinol. 2014 Jan 25;382(1):452-459. doi: 10.1016/j.mce.2013.09.035. Epub 2013 Oct 11. Review.

PMID:
24121199
12.

Integrating microRNAs into the complexity of gonadotropin signaling networks.

León K, Gallay N, Poupon A, Reiter E, Dalbies-Tran R, Crepieux P.

Front Cell Dev Biol. 2013 Dec 27;1:3. doi: 10.3389/fcell.2013.00003. eCollection 2013. Review.

13.

Competing G protein-coupled receptor kinases balance G protein and β-arrestin signaling.

Heitzler D, Durand G, Gallay N, Rizk A, Ahn S, Kim J, Violin JD, Dupuy L, Gauthier C, Piketty V, Crépieux P, Poupon A, Clément F, Fages F, Lefkowitz RJ, Reiter E.

Mol Syst Biol. 2012 Jun 26;8:590. doi: 10.1038/msb.2012.22.

14.

Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors.

Bertrand J, Despeaux M, Joly S, Bourogaa E, Gallay N, Demur C, Bonnevialle P, Louache F, Maguer-Satta V, Vergnolle N, Payrastre B, Racaud-Sultan C.

Oncogene. 2012 Feb 9;31(6):694-705. doi: 10.1038/onc.2011.258. Epub 2011 Jul 4.

PMID:
21725365
15.

Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status.

Matondo M, Bousquet-Dubouch MP, Gallay N, Uttenweiler-Joseph S, Recher C, Payrastre B, Manenti S, Monsarrat B, Burlet-Schiltz O.

Leuk Res. 2010 Apr;34(4):498-506. doi: 10.1016/j.leukres.2009.09.020. Epub 2009 Oct 6.

PMID:
19811823
16.

The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia.

Gallay N, Dos Santos C, Cuzin L, Bousquet M, Simmonet Gouy V, Chaussade C, Attal M, Payrastre B, Demur C, Récher C.

Leukemia. 2009 Jun;23(6):1029-38. doi: 10.1038/leu.2008.395. Epub 2009 Jan 22.

PMID:
19158829
17.

PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.

Park S, Chapuis N, Bardet V, Tamburini J, Gallay N, Willems L, Knight ZA, Shokat KM, Azar N, Viguié F, Ifrah N, Dreyfus F, Mayeux P, Lacombe C, Bouscary D.

Leukemia. 2008 Sep;22(9):1698-706. doi: 10.1038/leu.2008.144. Epub 2008 Jun 12.

PMID:
18548104
18.

Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells.

Delorme B, Ringe J, Gallay N, Le Vern Y, Kerboeuf D, Jorgensen C, Rosset P, Sensebé L, Layrolle P, Häupl T, Charbord P.

Blood. 2008 Mar 1;111(5):2631-5. Epub 2007 Dec 17.

PMID:
18086871
19.

The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.

Gallay N, Anani L, Lopez A, Colombat P, Binet C, Domenech J, Weksler BB, Malavasi F, Herault O.

Cancer Res. 2007 Sep 15;67(18):8624-32.

20.

The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.

Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, Charbord P, Domenech J.

Stem Cells. 2007 Jul;25(7):1737-45. Epub 2007 Mar 29.

21.

Synthesis and biological evaluation of 7-azaindole derivatives, synthetic cytokinin analogues.

Guillard J, Decrop M, Gallay N, Espanel C, Boissier E, Herault O, Viaud-Massuard MC.

Bioorg Med Chem Lett. 2007 Apr 1;17(7):1934-7. Epub 2007 Jan 19.

PMID:
17300934
22.

Molecular profile of mouse stromal mesenchymal stem cells.

Chateauvieux S, Ichanté JL, Delorme B, Frouin V, Piétu G, Langonné A, Gallay N, Sensebé L, Martin MT, Moore KA, Charbord P.

Physiol Genomics. 2007 Apr 24;29(2):128-38. Epub 2006 Dec 19.

PMID:
17179208
23.

CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia.

Dommange F, Cartron G, Espanel C, Gallay N, Domenech J, Benboubker L, Ohresser M, Colombat P, Binet C, Watier H, Herault O; GOELAMS Study Group.

FASEB J. 2006 Sep;20(11):1913-5. Epub 2006 Jul 3.

PMID:
16818471
24.

Pharmacological doses of all-trans retinoic acid promote G0/G1 transition and G1 arrest of normal human marrow CD34+ cells.

Herault O, Gallay N, Domenech J, Colombat P, Binet C.

Cell Death Differ. 2004 Dec;11 Suppl 2:S207-9. No abstract available.

Supplemental Content

Loading ...
Support Center